XOMA Royalty (XOMA) Non Operating Investment Income (2024 - 2026)
XOMA Royalty (XOMA) reported Non Operating Investment Income of $933000.0 for Q1 2026, up 0.65% on a YoY basis from $927000.0 in Q1 2025, and up 12.0% sequentially from $833000.0 in Q4 2025.
XOMA Royalty (XOMA) Non Operating Investment Income (2024 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 3 years of Non Operating Investment Income data on file, last reported at $933000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Investment Income rose 0.65% year-over-year to $933000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (down 38.1% YoY), and the FY2025 full-year result was $3.5 million, down 46.56% from the prior year.
- Non Operating Investment Income advanced to $933000.0 in Q1 2026, from $833000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $1.7 million in Q3 2024 to a low of $833000.0 in Q4 2025.
- A 3-year average of $1.2 million and a median of $933000.0 in 2026 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income slumped 49.88% in 2025 and gained 0.65% in 2026, its largest moves.
- Tracing XOMA's Non Operating Investment Income over 3 years: stood at $1.4 million in 2024, then tumbled by 40.71% to $833000.0 in 2025, then gained by 12.0% to $933000.0 in 2026.
- Business Quant data shows XOMA's Non Operating Investment Income at $933000.0 in Q1 2026, $833000.0 in Q4 2025, and $843000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 933,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 933,000.00 |
| Mar 31, 2026 | 933,000.00 |
| Dec 31, 2025 | 833,000.00 |
| Dec 31, 2025 | 833,000.00 |
| Jun 30, 2025 | 843,000.00 |
| Jun 30, 2025 | 843,000.00 |
| Mar 31, 2025 | 927,000.00 |
| Mar 31, 2025 | 927,000.00 |
| Dec 31, 2024 | 1.41 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |